GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » Shareholder Yield %

TRGM (Targeted Medical Pharma) Shareholder Yield % : 0.00% (As of Dec. 2015)


View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma Shareholder Yield %?

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Targeted Medical Pharma's Shareholder Yield % was 0.00%.


Targeted Medical Pharma Shareholder Yield % Historical Data

The historical data trend for Targeted Medical Pharma's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Targeted Medical Pharma Shareholder Yield % Chart

Targeted Medical Pharma Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Shareholder Yield %
Get a 7-Day Free Trial - - - - -

Targeted Medical Pharma Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Targeted Medical Pharma's Shareholder Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Targeted Medical Pharma's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Targeted Medical Pharma's Shareholder Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Targeted Medical Pharma's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Targeted Medical Pharma's Shareholder Yield % falls into.



Targeted Medical Pharma Shareholder Yield % Calculation

Targeted Medical Pharma's Shareholder Yield % for the quarter that ended in Dec. 2015 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0 %+0 %+-239.18 %
=-239.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.


Targeted Medical Pharma  (OTCPK:TRGM) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Targeted Medical Pharma Shareholder Yield % Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's Shareholder Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Targeted Medical Pharma Business Description

Traded in Other Exchanges
N/A
Address
2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077
Targeted Medical Pharma Inc is a medical nutrition company that develops amino acid based medical foods and other oral nutrition products for the long term management of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep, respiratory disorders, allergies and cognitive disorders.
Executives
William B. Horne officer: Chief Financial Officer C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald director C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb director MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph officer: See Remarks C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour director, 10 percent owner, officer: Former President C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher director 12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke officer: Chief Financial Officer C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc 10 percent owner, other: Former 10% Owner 269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel director, officer: Vice President 16178 EAST PRETENCE PLZ, AURORA CO 80015

Targeted Medical Pharma Headlines

No Headlines